Keyphrases
Clinical Trials
100%
L-carnitine
100%
Valproic Acid
100%
Spinal muscular Atrophy Type I
100%
Adverse Events
50%
Nerve
25%
Matched Cohort
25%
Multicenter Trial
25%
Therapeutic Potential
25%
Survival Time
25%
Motor Outcome
25%
Spinal muscular Atrophy
25%
Compound muscle Action Potential
25%
Time Since Death
25%
Ulnar
25%
Safety Potential
25%
Respiratory Events
25%
Retrospective Comparison
25%
Safety Events
25%
Action Potential Amplitude
25%
Ventilator Support
25%
Infant Reaching
25%
Medicine and Dentistry
Clinical Trial
100%
Carnitine
100%
Sodium Valproate
100%
Werdnig Hoffmann Disease
100%
Adverse Event
50%
Symptomatic Treatment
25%
Survival Time
25%
Muscle Innervation
25%
Spinal Muscular Atrophy
25%
Action Potential Amplitude
25%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Carnitine
100%
Sodium Valproate
100%
Werdnig Hoffmann Disease
100%
Adverse Event
50%
Survival Time
25%
Spinal Muscular Atrophy
25%